Evaluating the Feasibility of Prehabilitation Delivery Models for Patients Preparing for Gynecologic Cancer Surgery
NCT07609082
Summary
The goal of this clinical trial is to learn whether high-dose multimodal prehabilitation, delivered either in person or remotely with coaching and web application support, is feasible and acceptable for women preparing for primary surgery for suspected gynecologic malignancy. It will also examine which delivery model patients prefer and the factors influencing patient preferences. The main questions ADAPT aims to answer are: 1. Can participants achieve the prescribed aerobic exercise target of at least 10 MET-hours per week before surgery? 2. Do patients prefer in-person prehabilitation, remote prehabilitation, or education-only care, and what factors influence that preference? The researchers will compare in-person prehabilitation, remote prehabilitation, and education-only care to see which delivery approach is most feasible, acceptable, and practical for patients with suspected gynecologic cancer. Participants will: * Choose their preferred study group, or be randomly assigned if they have no preference * Complete patient-reported questionnaires and semi-structured interviews at baseline, 1-3 days before surgery, and 4 weeks after surgery * If assigned to a prehabilitation group, complete aerobic exercise, protein supplementation, and daily breathing exercises before surgery * Attend weekly coaching sessions with a trained prehabilitation coach * Use the KingstonPrehab web application to track exercise, nutrition, breathing practice, and progress toward activity goals
Eligibility
Inclusion Criteria: * Female * Aged ≥18 years * Scheduled for cytoreductive surgery for a gynecologic mass suspected or confirmed of cancer * Surgery planned ≥3 weeks from time of booking * No contraindications to exercise on the CSEP Get Active Questionnaire * Able to provide written informed consent * Able to understand and communicate in English Exclusion Criteria: * Pregnancy * Cervical pathologies * Surgery scheduled \<3 weeks from booking * Receiving neoadjuvant chemotherapy * Positive contraindications to exercise on the CSEP Get Active Questionnaire * End-stage or advanced renal disease limiting safe protein supplementation * Malnutrition as assessed by a registered dietician
Conditions7
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07609082